Toll Free: 1-888-928-9744

Allergic Asthma - Pipeline Review, H2 2016

Published: Aug, 2016 | Pages: 181 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Allergic Asthma - Pipeline Review, H2 2016

Summary

Global Markets Direct's, 'Allergic Asthma - Pipeline Review, H2 2016', provides an overview of the Allergic Asthma pipeline landscape. 

The report provides comprehensive information on the therapeutics under development for Allergic Asthma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Allergic Asthma and features dormant and discontinued projects. 

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the global therapeutic landscape of Allergic Asthma
- The report reviews pipeline therapeutics for Allergic Asthma by companies and universities/research institutes based on information derived from company and industry-specific sources 
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages 
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities 
- The report reviews key players involved Allergic Asthma therapeutics and enlists all their major and minor projects
- The report assesses Allergic Asthma therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type 
- The report summarizes all the dormant and discontinued pipeline projects 
- The report reviews latest news related to pipeline therapeutics for Allergic Asthma

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage 
- Identify and understand important and diverse types of therapeutics under development for Allergic Asthma
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies 
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Allergic Asthma pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
 Table of Contents
Table of Contents 2 List of Tables 5 List of Figures 6 Introduction 7 Global Markets Direct Report Coverage 7 Allergic Asthma Overview 8 Therapeutics Development 9 Pipeline Products for Allergic Asthma - Overview 9 Pipeline Products for Allergic Asthma - Comparative Analysis 10 Allergic Asthma - Therapeutics under Development by Companies 11 Allergic Asthma - Therapeutics under Investigation by Universities/Institutes 14 Allergic Asthma - Pipeline Products Glance 15 Late Stage Products 15 Clinical Stage Products 16 Early Stage Products 17 Allergic Asthma - Products under Development by Companies 18 Allergic Asthma - Products under Investigation by Universities/Institutes 21 Allergic Asthma - Companies Involved in Therapeutics Development 22 ALK-Abello A/S 22 Allergopharma GmbH & Co. KG 23 Amgen Inc. 24 Aquinox Pharmaceuticals Inc. 25 ASIT biotech s.a. 26 Aslan Pharmaceuticals Pte. Ltd. 27 Chiesi Farmaceutici SpA 28 Circassia Pharmaceuticals Plc 29 CSL Limited 30 F. Hoffmann-La Roche Ltd. 31 Fountain Biopharma Inc. 32 Genentech, Inc. 33 GlaxoSmithKline Plc 34 Hydra Biosciences, Inc. 35 Infinity Pharmaceuticals, Inc. 36 KPI Therapeutics, Inc. 37 Mabtech Limited 38 Marinomed Biotechnologie GmbH 39 Mycenax Biotech Inc. 40 NeoPharm Co., Ltd. 41 Oxagen Limited 42 Panacea Biotec Limited 43 Paradigm Biopharmaceuticals Limited 44 Pharmaxis Limited 45 Protectimmun GmbH 46 Shire Plc 47 Stallergenes Greer plc 48 sterna biologicals Gmbh & Co KG 49 Swecure AB 50 Synermore Biologics Co Ltd 51 The International Biotechnology Center (IBC) Generium 52 Verona Pharma Plc 53 Xencor, Inc. 54 Allergic Asthma - Therapeutics Assessment 55 Assessment by Monotherapy Products 55 Assessment by Combination Products 56 Assessment by Target 57 Assessment by Mechanism of Action 60 Assessment by Route of Administration 63 Assessment by Molecule Type 65 Drug Profiles 67 AcTMP-1 - Drug Profile 67 Allergen for Allergic Asthma and Allergic Rhinitis - Drug Profile 68 AQX-1125 - Drug Profile 69 Arabinogalactan - Drug Profile 74 ASLAN-004 - Drug Profile 75 ASM-8 - Drug Profile 76 beta-escin - Drug Profile 78 CHF-6001 - Drug Profile 79 CSL-311 - Drug Profile 81 dalazatide - Drug Profile 82 Drug to Inhibit PI3 Kinase Delta for Asthma - Drug Profile 87 duvelisib - Drug Profile 88 EP-67 - Drug Profile 99 Epsi-Gam - Drug Profile 100 FB-825 - Drug Profile 102 GNR-044 - Drug Profile 103 GSK-2245035 - Drug Profile 104 hdm-ASIT - Drug Profile 106 HX-100 - Drug Profile 107 Lactococcus lactis G121 - Drug Profile 109 Leukothera - Drug Profile 110 OC-000459 - Drug Profile 111 OC-2417 - Drug Profile 113 omalizumab biosimilar - Drug Profile 114 omalizumab biosimilar - Drug Profile 115 omalizumab biosimilar - Drug Profile 116 omalizumab biosimilar - Drug Profile 117 omalizumab biosimilar - Drug Profile 118 OND-86 - Drug Profile 119 pemirolast potassium - Drug Profile 120 pentosan polysulfate sodium - Drug Profile 121 RG-6149 - Drug Profile 122 RG-7990 - Drug Profile 123 RPL-554 - Drug Profile 124 SB-010 - Drug Profile 132 SG-100 - Drug Profile 134 SM-301 - Drug Profile 136 Small Molecule for Allergic Asthma - Drug Profile 137 Small Molecules for Allergic Asthma - Drug Profile 138 Small Molecules to Inhibit 5-Lipoxygenase for Allergic Asthma - Drug Profile 139 Small Molecules to Inhibit CaMKII for Allergic Asthma - Drug Profile 140 standardized grass pollen [timothy (Phleum pratense)] allergen extract - Drug Profile 141 standardized mite (Dermatophagoides farinae + Dermatophagoides pteronyssinus) allergen extract - Drug Profile 144 standardized mite (Dermatophagoides pteronyssinus + Dermatophagoides farinae) allergen vaccine - Drug Profile 146 SWE-01 - Drug Profile 151 Synthetic Peptides for Allergic Asthma and Rheumatoid Arthritis - Drug Profile 152 tezepelumab - Drug Profile 153 Vaccine for Allergic Asthma - Drug Profile 155 Vaccine for Grass-Induced Rhinoconjunctivitis and Asthma - Drug Profile 156 XmAb-7195 - Drug Profile 158 Allergic Asthma - Dormant Projects 159 Allergic Asthma - Discontinued Products 163 Allergic Asthma - Product Development Milestones 164 Featured News & Press Releases 164 Appendix 176 Methodology 176 Coverage 176 Secondary Research 176 Primary Research 176 Expert Panel Validation 176 Contact Us 176 Disclaimer 177
List of Tables
Number of Products under Development for Allergic Asthma, H2 2016 13 Number of Products under Development for Allergic Asthma - Comparative Analysis, H2 2016 14 Number of Products under Development by Companies, H2 2016 16 Number of Products under Development by Companies, H2 2016 (Contd..1) 17 Number of Products under Investigation by Universities/Institutes, H2 2016 18 Comparative Analysis by Late Stage Development, H2 2016 19 Comparative Analysis by Clinical Stage Development, H2 2016 20 Comparative Analysis by Early Stage Development, H2 2016 21 Products under Development by Companies, H2 2016 22 Products under Development by Companies, H2 2016 (Contd..1) 23 Products under Development by Companies, H2 2016 (Contd..2) 24 Products under Investigation by Universities/Institutes, H2 2016 25 Allergic Asthma - Pipeline by ALK-Abello A/S, H2 2016 26 Allergic Asthma - Pipeline by Allergopharma GmbH & Co. KG, H2 2016 27 Allergic Asthma - Pipeline by Amgen Inc., H2 2016 28 Allergic Asthma - Pipeline by Aquinox Pharmaceuticals Inc., H2 2016 29 Allergic Asthma - Pipeline by ASIT biotech s.a., H2 2016 30 Allergic Asthma - Pipeline by Aslan Pharmaceuticals Pte. Ltd., H2 2016 31 Allergic Asthma - Pipeline by Chiesi Farmaceutici SpA, H2 2016 32 Allergic Asthma - Pipeline by Circassia Pharmaceuticals Plc, H2 2016 33 Allergic Asthma - Pipeline by CSL Limited, H2 2016 34 Allergic Asthma - Pipeline by F. Hoffmann-La Roche Ltd., H2 2016 35 Allergic Asthma - Pipeline by Fountain Biopharma Inc., H2 2016 36 Allergic Asthma - Pipeline by Genentech, Inc., H2 2016 37 Allergic Asthma - Pipeline by GlaxoSmithKline Plc, H2 2016 38 Allergic Asthma - Pipeline by Hydra Biosciences, Inc., H2 2016 39 Allergic Asthma - Pipeline by Infinity Pharmaceuticals, Inc., H2 2016 40 Allergic Asthma - Pipeline by KPI Therapeutics, Inc., H2 2016 41 Allergic Asthma - Pipeline by Mabtech Limited, H2 2016 42 Allergic Asthma - Pipeline by Marinomed Biotechnologie GmbH, H2 2016 43 Allergic Asthma - Pipeline by Mycenax Biotech Inc., H2 2016 44 Allergic Asthma - Pipeline by NeoPharm Co., Ltd., H2 2016 45 Allergic Asthma - Pipeline by Oxagen Limited, H2 2016 46 Allergic Asthma - Pipeline by Panacea Biotec Limited, H2 2016 47 Allergic Asthma - Pipeline by Paradigm Biopharmaceuticals Limited, H2 2016 48 Allergic Asthma - Pipeline by Pharmaxis Limited, H2 2016 49 Allergic Asthma - Pipeline by Protectimmun GmbH, H2 2016 50 Allergic Asthma - Pipeline by Shire Plc, H2 2016 51 Allergic Asthma - Pipeline by Stallergenes Greer plc, H2 2016 52 Allergic Asthma - Pipeline by sterna biologicals Gmbh & Co KG, H2 2016 53 Allergic Asthma - Pipeline by Swecure AB, H2 2016 54 Allergic Asthma - Pipeline by Synermore Biologics Co Ltd, H2 2016 55 Allergic Asthma - Pipeline by The International Biotechnology Center (IBC) Generium, H2 2016 56 Allergic Asthma - Pipeline by Verona Pharma Plc, H2 2016 57 Allergic Asthma - Pipeline by Xencor, Inc., H2 2016 58 Assessment by Monotherapy Products, H2 2016 59 Assessment by Combination Products, H2 2016 60 Number of Products by Stage and Target, H2 2016 62 Number of Products by Stage and Mechanism of Action, H2 2016 65 Number of Products by Stage and Route of Administration, H2 2016 68 Number of Products by Stage and Molecule Type, H2 2016 70 Allergic Asthma - Dormant Projects, H2 2016 163 Allergic Asthma - Dormant Projects (Contd..1), H2 2016 164 Allergic Asthma - Dormant Projects (Contd..2), H2 2016 165 Allergic Asthma - Dormant Projects (Contd..3), H2 2016 166 Allergic Asthma - Discontinued Products, H2 2016 167



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $2000
Multi User - US $4000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify